Bristol-Myers Squibb
BMY
#207
Rank
$95.48 B
Marketcap
$46.49
Share price
-0.92%
Change (1 day)
16.25%
Change (1 year)

Bristol-Myers Squibb (BMY) - P/B ratio

P/B ratio as of July 2025 : 5.47

According to Bristol-Myers Squibb's latest financial reports the company has a price-to-book ratio of 2.00449.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Bristol-Myers Squibb - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-317.14101.6%
2023-12-313.54-27.97%
2022-12-314.9227.9%
2021-12-313.843.88%
2020-12-313.7033.76%
2019-12-312.77-53.7%
2018-12-315.98-29.42%
2017-12-318.4741.7%
2016-12-315.97-24.58%
2015-12-317.9221.64%
2014-12-316.5113.76%
2013-12-315.7246.97%
2012-12-313.903.5%
2011-12-313.7630.82%
2010-12-312.88-1.43%
2009-12-312.92-22.59%
2008-12-313.77-23.94%
2007-12-314.96-4.1%
2006-12-315.1728.81%
2005-12-314.01-17.94%
2004-12-314.89-13.76%
2003-12-315.679.77%
2002-12-315.17

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.59-70.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.20-23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
44.2 708.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.35 15.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
1.47-73.11%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
5.25-4.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
4.81-12.19%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
229 4,078.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
25.8 372.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
1.15-79.05%๐Ÿ‡บ๐Ÿ‡ธ USA